PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation

by Ahrum Min, Seock-Ah Im
Published 2020-02-01

Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: Prognostic Value Measured with Gini’s Mean Difference of Restricted Mean Survival Times

by Bhumsuk Keam, Olena Gorobets, Vincent Vinh-Hung, Seock-Ah Im
Published 2021-10-01

HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor

by Hyeyeon Chang, Yong‐Won Shin, Bhumsuk Keam, Miso Kim, Seock‐Ah Im, Soon‐Tae Lee
Published 2020-11-01

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab

by Jung Won Shin, Soohyun Kim, Suji Ha, Byungsan Choi, Seongyeong Kim, Seock-Ah Im, Tae-Young Yoon, Junho Chung
Published 2019-10-01

HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless o...

by Jeongmin Seo, Jiwon Koh, Dae-Won Lee, Jinyong Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im
Published 2023-12-01

Development of a Novel Orthotopic Gastric Cancer Mouse Model

by Wonyoung Kang, Leigh Maher, Michael Michaud, Seong-Woo Bae, Seongyeong Kim, Hye Seung Lee, Seock-Ah Im, Han-Kwang Yang, Charles Lee
Published 2021-01-01

Correction to: Development of a Novel Orthotopic Gastric Cancer Mouse Model

by Wonyoung Kang, Leigh Maher, Michael Michaud, Seong-Woo Bae, Seongyeong Kim, Hye Seung Lee, Seock-Ah Im, Han-Kwang Yang, Charles Lee
Published 2021-04-01

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.

by Younak Choi, Do-Youn Oh, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang
Published 2015-01-01

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

by Jinyong Kim, Jiyun Jeong, Jiyun Jeong, Chan Mi Lee, Dae-Won Lee, Chang Kyung Kang, Pyeong Gyun Choe, Nam Joong Kim, Myoung-don Oh, Chang-Han Lee, Chang-Han Lee, Chang-Han Lee, Chang-Han Lee, Wan Beom Park, Kyung-Hun Lee, Kyung-Hun Lee, Seock-Ah Im, Seock-Ah Im
Published 2022-11-01

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer:...

by Johannes Ettl, Seock-Ah Im, Jungsil Ro, Norikazu Masuda, Marco Colleoni, Patrick Schnell, Eustratios Bananis, Dongrui R. Lu, Massimo Cristofanilli, Hope S. Rugo, Richard S. Finn
Published 2020-03-01

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity.

by Younak Choi, Do-Youn Oh, Hyunkyung Park, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang
Published 2016-01-01

The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

by Ji Eun Choi, Jae Seok Lee, Min-Sun Jin, Ilias P. Nikas, Kwangsoo Kim, Sunah Yang, Soo Young Park, Jiwon Koh, Sohyeon Yang, Seock-Ah Im, Han Suk Ryu
Published 2023-11-01

The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology

by Kelly A. Hirko, Gabrielle Rocque, Erica Reasor, Ammanuel Taye, Alex Daly, Ramsey I. Cutress, Ellen R. Copson, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im, Yeon Hee Park
Published 2022-02-01

Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER...

by Soohyeon Lee, Kyunghee Park, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Woong-Yang Park, Seock-Ah Im, Yeon Hee Park
Published 2022-04-01

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

by Dae-Won Lee, Kyung-Hun Lee, Hee-Jun Kim, Tae-Yong Kim, Jin-Soo Kim, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Seock-Ah Im, Tae-You Kim
Published 2018-03-01

Intensity of metastasis screening and survival outcomes in patients with breast cancer

by Jong-Ho Cheun, Jigwang Jung, Eun-Shin Lee, Jiyoung Rhu, Han-Byoel Lee, Kyung-Hun Lee, Tae-Yong Kim, Wonshink Han, Seock-Ah Im, Dong-Young Noh, Hyeong-Gon Moon
Published 2021-02-01

Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

by Hwang-Phill Kim, Young-Kwang Yoon, Jin-Won Kim, Sae-Won Han, Hyung-Seok Hur, Jinah Park, Ju-Hee Lee, Do-Youn Oh, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim
Published 2009-01-01

Corrigendum to “Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced...

by Massimo Cristofanilli, Nadia Harbeck, Hope S. Rugo, Aurelio Castrellon, Anil Abraham Joy, Sunil Verma, Seock-Ah Im, Shrividya Iyer, Kathy Puyana Theall, Eric Gauthier, Xin Huang, Cynthia Huang Bartlett, Sibylle Loibl, Richard S. Finn
Published 2020-02-01

Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative a...

by Hope S. Rugo, Seock-Ah Im, Anil A. Joy, Yaroslav Shparyk, Janice M. Walshe, Bethany Sleckman, Sherene Loi, Kathy Puyana Theall, Sindy Kim, Xin Huang, Eustratios Bananis, Reshma Mahtani, Richard S. Finn, Véronique Diéras
Published 2022-12-01

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations

by Jinyong Kim, Kyeonghun Jeong, Hyeji Jun, Kwangsoo Kim, Jeong Mo Bae, Myung Geun Song, Hanbaek Yi, Songyi Park, Go-un Woo, Dae-Won Lee, Tae-Yong Kim, Kyung-Hun Lee, Seock-Ah Im
Published 2023-01-01